Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Approach to the Evaluation of Breast Masses Using Doppler Ultrasonography: Percentage Changes in Resistive Index Between the Mass and Surrounding Normal Parenchyma in Benign-Malignant Differentiation

NCT07465523 is registered in ClinicalTrials.gov with Ahmet Yesildag as lead sponsor.

NCT NCT07465523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07465523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Approach to the Evaluation of Breast Masses Using Doppler Ultrasonography: Percentage Changes in Resistive Index Between the Mass and Surrounding Normal Parenchyma in Benign-Malignant Differentiation
Lead sponsor
Ahmet Yesildag
Phase
Observational
Overall status
Recruiting
Start date
March 4, 2026
Completion date
May 19, 2026
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign breast neoplasm, breast neoplasm female, doppler ultrasound diagnosis, malign breast neoplasm